HAO vs. SOPA, LIFW, PAVS, FTFT, SUGP, ATXG, ZBAI, SPPL, RVYL, and CREG
Should you be buying Haoxi Health Technology stock or one of its competitors? The main competitors of Haoxi Health Technology include Society Pass (SOPA), MSP Recovery (LIFW), Paranovus Entertainment Technology (PAVS), Future FinTech Group (FTFT), SU Group (SUGP), Addentax Group (ATXG), ATIF (ZBAI), Simpple (SPPL), Ryvyl (RVYL), and Smart Powerr (CREG). These companies are all part of the "business services" industry.
Haoxi Health Technology vs. Its Competitors
Society Pass (NASDAQ:SOPA) and Haoxi Health Technology (NASDAQ:HAO) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.
Haoxi Health Technology has a net margin of 0.00% compared to Society Pass' net margin of -137.06%. Haoxi Health Technology's return on equity of 0.00% beat Society Pass' return on equity.
Society Pass has a beta of 1.8, indicating that its share price is 80% more volatile than the S&P 500. Comparatively, Haoxi Health Technology has a beta of -0.48, indicating that its share price is 148% less volatile than the S&P 500.
Society Pass presently has a consensus price target of $15.00, suggesting a potential upside of 1,150.00%. Given Society Pass' stronger consensus rating and higher possible upside, equities research analysts plainly believe Society Pass is more favorable than Haoxi Health Technology.
Haoxi Health Technology has higher revenue and earnings than Society Pass.
In the previous week, Society Pass had 1 more articles in the media than Haoxi Health Technology. MarketBeat recorded 2 mentions for Society Pass and 1 mentions for Haoxi Health Technology. Haoxi Health Technology's average media sentiment score of 1.89 beat Society Pass' score of 0.94 indicating that Haoxi Health Technology is being referred to more favorably in the news media.
3.1% of Society Pass shares are owned by institutional investors. 5.6% of Society Pass shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Society Pass beats Haoxi Health Technology on 8 of the 14 factors compared between the two stocks.
Get Haoxi Health Technology News Delivered to You Automatically
Sign up to receive the latest news and ratings for HAO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HAO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Haoxi Health Technology Competitors List
Related Companies and Tools
This page (NASDAQ:HAO) was last updated on 7/16/2025 by MarketBeat.com Staff
Free HAO Stock Alerts